allscripts

Analysts at Stifel have initiated coverage on Allscripts Healthcare Solutions Inc (NASDAQ: MDRX). In a report released Tuesday, analysts issued a Hold rating on Allscripts stock and explained that they see limited growth opportunities for the company. ‘Difficult' Turnaround Analysts...

According to Piper Jaffray, Allscripts (NASDAQ: MDRX) announced that John Gomez (CTO) will leave the company effective May 31st but will remain as a consultant for 18 months. Piper Jaffray reported that it believes that John is the key executive to drive MDRX-ECLP technology/product integration...

Deutsche Bank is out with its "Health IT Update" today, and it reiterates Buy on Allscripts (NASDAQ: MDRX). In a note to clients, Deutsche Bank writes, "Given the pending start of the attestation period for meaningful use certification, we have analyzed the implied EPS growth for the EHR vendors...

Piper Jaffray has published a Health Care Services: Information Technology report with key takeaways which are as follows: "Sharp [Healthcare] is one of about a dozen hospitals that have both Cerner and Allscripts. Getting the two vendors to cooperate has been challenging at times. At the root of...